Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort ascending Intervention NCT ID Sponsor Status
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline NCT02134925 National Cancer Institute (NCI) Active, not recruiting
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim NCT02780401 University of Washington Recruiting
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration NCT02314156 Northwestern University Active, not recruiting
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial... Imiquimod, Laboratory Biomarker Analysis, Topical Fluorouracil NCT03196180 National Cancer Institute (NCI) Not yet recruiting
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate NCT02993159 Northwestern University Recruiting
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin NCT02743364 National Cancer Institute (NCI) Active, not recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Simvastatin NCT02968810 National Cancer Institute (NCI) Recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Retinoid 9cUAB30, Therapeutic Conventional Surgery NCT02876640 National Cancer Institute (NCI) Recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Placebo, Rilimogene Galvacirepvec NCT02326805 National Cancer Institute (NCI) Active, not recruiting

Pages